Ameriprise Financial Inc Pmv Pharmaceuticals, Inc. Transaction History

Ameriprise Financial Inc

$356 Billion
Q1 2025

A detailed history of Ameriprise Financial Inc transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 18,007 shares of PMVP stock, worth $20,888. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,007

Previous 22,807 21.05%

Holding current value

$20,888

Previous $34,000 44.12%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$1.09 - $1.57 $5,232 - $7,536	-4,800 Reduced 21.05%	18,007 $19,000
Q4 2024 Feb 14, 2025	SELL	$1.47 - $1.78 $24,571 - $29,752	-16,715 Reduced 42.29%	22,807 $34,000
Q3 2024 Nov 14, 2024	SELL	$1.44 - $1.69 $14,791 - $17,359	-10,272 Reduced 20.63%	39,522 $58,000
Q1 2024 May 15, 2024	SELL	$1.51 - $3.12 $114,134 - $235,828	-75,586 Reduced 60.29%	49,794 $84,000
Q4 2023 Feb 14, 2024	BUY	$1.23 - $6.6 $53,129 - $285,087	43,195 Added 52.56%	125,380 $388,000
Q3 2023 Nov 14, 2023	BUY	$6.01 - $8.93 $5,198 - $7,724	865 Added 1.06%	82,185 $504,000
Q2 2023 Aug 14, 2023	SELL	$3.94 - $6.27 $1,122 - $1,786	-285 Reduced 0.35%	81,320 $509,000
Q1 2023 May 15, 2023	BUY	$4.77 - $9.16 $6,105 - $11,724	1,280 Added 1.59%	81,605 $389,000
Q4 2022 Feb 14, 2023	SELL	$8.17 - $12.95 $40 - $64	-5 Reduced 0.01%	80,325 $698,000
Q3 2022 Nov 14, 2022	SELL	$11.4 - $17.18 $17,339 - $26,130	-1,521 Reduced 1.86%	80,330 $956,000
Q2 2022 Aug 15, 2022	BUY	$9.23 - $22.43 $205,441 - $499,246	22,258 Added 37.35%	81,851 $1.17 Million
Q1 2022 May 16, 2022	BUY	$14.86 - $23.55 $118,969 - $188,541	8,006 Added 15.52%	59,593 $1.24 Million
Q4 2021 Feb 14, 2022	BUY	$19.99 - $30.24 $387,226 - $585,779	19,371 Added 60.13%	51,587 $1.19 Million
Q3 2021 Nov 15, 2021	SELL	$26.84 - $36.58 $80,251 - $109,374	-2,990 Reduced 8.49%	32,216 $960,000
Q2 2021 Aug 16, 2021	BUY	$28.01 - $36.01 $501,014 - $644,110	17,887 Added 103.28%	35,206 $1.14 Million
Q1 2021 May 17, 2021	BUY	$30.66 - $49.5 $420,225 - $678,447	13,706 Added 379.35%	17,319 $570,000
Q4 2020 Feb 12, 2021	BUY	$31.86 - $61.51 $115,110 - $222,235	3,613 New	3,613 $222,000

Others Institutions Holding PMVP

# of Institutions

Shares Held

40.2M

Call Options Held

1.8K

Put Options Held

100

View Full List

About PMV Pharmaceuticals, Inc.

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $52.9M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

More about PMVP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Pmv Pharmaceuticals, Inc. Transaction History